SLC30A8 (Q8IWU4) variants and mutations
SLC30A8 (also known as Q8IWU4) is a human protein-coding gene encoding a proton-coupled zinc antiporter protein. It transports zinc into insulin secretory granules, supporting insulin crystallization, storage, and beta-cell function. Common variants influence type 2 diabetes risk, while rare loss-of-function variants are associated with reduced disease risk in population studies. This analysis covers 716 SLC30A8 variants and mutations. Of these, 94% have computational variant effect predictions. Disease context includes type 2 diabetes mellitus, diabetes mellitus, and diabetic retinopathy. Example SLC30A8 variants include M1?, E2G, and E2K.
Variant analysis overview
- Gene: SLC30A8
- Protein: Q8IWU4
- UniProt accession: Q8IWU4
- Organism: Homo sapiens
- Variants analyzed: 716
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 503 unspecified-consequence records; 86 synonymous variants; 103 missense variants; 18 frameshift variants; 3 splice-region variants; 3 in-frame insertions
- Prediction scores: 671 variants have prediction scores (94% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: type 2 diabetes mellitus, diabetes mellitus, diabetic retinopathy, diabetic neuropathy, diabetic eye disease, gestational diabetes, type 2 diabetes nephropathy, diabetic polyneuropathy, type 1 diabetes mellitus, metabolic syndrome, glucose metabolism disease, psoriasis.
Protein structure and variant hotspots
- Protein features: 6 transmembrane segments; 14 binding sites.
- Structural context: 246 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SLC30A8 variants
Examples include M1?, E2G, E2K, E2E, F3I, L4F, L4P, L4L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV6997, Variant assessed as somatic; high impact.
- E2G (p.Glu2Gly), ESP rs370648372, ExAC rs370648372, TOPMed rs370648372, gnomAD rs370648372, REVEL 0.14, CADD 24.60
- E2K (p.Glu2Lys), NCI-TCGA Cosmic COSV6997, SIFT 0.17, Variant assessed as somatic; moderate impact.
- E2E (p.Glu2Glu), rs766192430, gnomAD 8-117135333-G-A, CADD 4.63
- F3I (p.Phe3Ile), NCI-TCGA Cosmic COSV6997, SIFT 0.26, Variant assessed as somatic; moderate impact.
- L4F (p.Leu4Phe), gnomAD 8-117135337-C-T, REVEL 0.03, CADD 18.30
- L4P (p.Leu4Pro), gnomAD 8-117135338-T-C, REVEL 0.09, CADD 16.20
- L4L (p.Leu4Leu), rs140569332, gnomAD 8-117135339-T-C, CADD 2.24
- E5Q (p.Glu5Gln), gnomAD 8-117135340-G-C, REVEL 0.17, CADD 24.30
- R6G (p.Arg6Gly), gnomAD 8-117135343-A-G, REVEL 0.25, CADD 23.40
- T7K (p.Thr7Lys), ExAC rs755057304, TOPMed rs755057304, gnomAD rs755057304, REVEL 0.23, CADD 18.50, Uncertain significance
- T7M (p.Thr7Met), rs755057304, NCI-TCGA Cosmic COSV6997, ExAC rs755057304, TOPMed rs755057304, REVEL 0.21, CADD 22.30, Uncertain significance, not specified
- T7A (p.Thr7Ala), gnomAD 8-117135346-A-G, REVEL 0.03, CADD 18.90
- T7T (p.Thr7Thr), gnomAD 8-117135348-G-T, CADD 2.97
- Y8C (p.Tyr8Cys), ExAC rs758845299, gnomAD rs758845299, REVEL 0.13, CADD 17.80
- Y8L (p.Tyr8Leu), gnomAD 8-117135348-G-GT, CADD 24.40
- Y8Y (p.Tyr8Tyr), gnomAD 8-117135351-T-C, CADD 0.52
- L9L (p.Leu9Leu), gnomAD 8-117135354-T-C, CADD 1.30
- V10V (p.Val10Val), gnomAD 8-117135357-G-T, CADD 8.07
- N11H (p.Asn11His), ExAC rs778259024, TOPMed rs778259024, gnomAD rs778259024, REVEL 0.06, CADD 22.40, Uncertain significance, not specified
- N11I (p.Asn11Ile), TOPMed rs1821312496, REVEL 0.17, CADD 19.10
- N11K (p.Asn11Lys), Ensembl rs1821312676, SIFT 0.10
- N11S (p.Asn11Ser), TOPMed rs1821312496, REVEL 0.08, CADD 11.20
- N11D (p.Asn11Asp), gnomAD 8-117135358-A-G, REVEL 0.09, CADD 18.40
- N11N (p.Asn11Asn), gnomAD 8-117135360-T-C, CADD 5.71
- D12G (p.Asp12Gly), Ensembl rs2130932989
- D12N (p.Asp12Asn), NCI-TCGA Cosmic COSV6996, SIFT 0.08, Variant assessed as somatic; moderate impact.
- K13T (p.Lys13Thr), Ensembl rs1391496326, SIFT 0.01
- A14T (p.Ala14Thr), NCI-TCGA Cosmic COSV6996, REVEL 0.05, CADD 16.30, Variant assessed as somatic; moderate impact.
- A14D (p.Ala14Asp), gnomAD 8-117135368-C-A, REVEL 0.07, CADD 16.50
- A15D (p.Ala15Asp), NCI-TCGA Cosmic COSV1014, SIFT 0.09, Variant assessed as somatic; moderate impact.
- A15T (p.Ala15Thr), gnomAD rs1261230269, REVEL 0.07, CADD 10.80
- A15V (p.Ala15Val), gnomAD 8-117135371-C-T, REVEL 0.04, CADD 21.60
- A15A (p.Ala15Ala), gnomAD 8-117135372-C-A, CADD 7.79
- K16E (p.Lys16Glu), 1000Genomes rs558096588, REVEL 0.15, CADD 23.00
- K16R (p.Lys16Arg), gnomAD 8-117135374-A-G, REVEL 0.08, CADD 18.30
- M17I (p.Met17Ile), ExAC rs747329029, gnomAD rs747329029, SIFT 0.21
- M17V (p.Met17Val), Ensembl rs1821313659, REVEL 0.14, CADD 17.90
- M17C (p.Met17Cys), rs760522749, gnomAD 8-117135375-GA-G, CADD 25.90
- M17K (p.Met17Lys), gnomAD 8-117135377-T-A, REVEL 0.17, CADD 15.90
- Y18C (p.Tyr18Cys), 1000Genomes rs534016412, ExAC rs534016412, TOPMed rs534016412, gnomAD rs534016412, REVEL 0.26, CADD 24.90, Uncertain significance, not specified
- Y18D (p.Tyr18Asp), 1000Genomes rs201490156, ExAC rs201490156, gnomAD rs201490156, REVEL 0.35, CADD 22.80, Uncertain significance, not specified
- Y18H (p.Tyr18His), 1000Genomes rs201490156, ExAC rs201490156, gnomAD rs201490156, REVEL 0.14, CADD 23.90
- Y18F (p.Tyr18Phe), gnomAD 8-117135380-A-T, REVEL 0.13, CADD 20.00
- Y18Y (p.Tyr18Tyr), rs748828869, gnomAD 8-117135381-T-C, CADD 0.04
- A19V (p.Ala19Val), rs145638764, ESP rs145638764, ExAC rs145638764, TOPMed rs145638764, AlphaMissense 0.12, MetaLR 0.14, Variant assessed as somatic; moderate impact.
- A19P (p.Ala19Pro), gnomAD 8-117135382-G-C, REVEL 0.20, CADD 20.20
- A19T (p.Ala19Thr), gnomAD 8-117135382-G-A, REVEL 0.04, CADD 15.60
- A19A (p.Ala19Ala), gnomAD 8-117135384-T-C, CADD 8.15
- F20V (p.Phe20Val), gnomAD 8-117135385-T-G, REVEL 0.03, CADD 17.60
- F20S (p.Phe20Ser), gnomAD 8-117135386-T-C, REVEL 0.19, CADD 16.10
- F20L (p.Phe20Leu), gnomAD 8-117135387-C-A, REVEL 0.06, CADD 9.69
- T21A (p.Thr21Ala), gnomAD 8-117135388-A-G, REVEL 0.02, CADD 11.40
- T21T (p.Thr21Thr), rs1200370065, gnomAD 8-117135390-A-C, CADD 0.45
- L22I (p.Leu22Ile), 1000Genomes rs555484215, ExAC rs555484215, TOPMed rs555484215, gnomAD rs555484215, REVEL 0.03, CADD 8.76, Likely benign
- L22R (p.Leu22Arg), ExAC rs761514247, gnomAD rs761514247, REVEL 0.19, CADD 22.00
- L22V (p.Leu22Val), 1000Genomes rs555484215, ExAC rs555484215, TOPMed rs555484215, gnomAD rs555484215, SIFT 0.03, Likely benign
- L22L (p.Leu22Leu), rs555484215, gnomAD 8-117135391-C-T, CADD 4.60
- L22P (p.Leu22Pro), gnomAD 8-117135392-T-C, REVEL 0.20, CADD 21.90
- L22Q (p.Leu22Gln), gnomAD 8-117135392-T-A, REVEL 0.08, CADD 21.70
- E23D (p.Glu23Asp), ExAC rs771712748, gnomAD rs771712748, REVEL 0.05, CADD 9.95
- E23G (p.Glu23Gly), Ensembl rs2130933122, REVEL 0.06, CADD 20.30
- E23E (p.Glu23Glu), rs771712748, gnomAD 8-117135396-A-G, CADD 11.50
- S24N (p.Ser24Asn), gnomAD rs1364809645, REVEL 0.09, CADD 33.00
- S24R (p.Ser24Arg), 1000Genomes rs144023942, ESP rs144023942, ExAC rs144023942, TOPMed rs144023942, SIFT 0.31, Benign
- S24S (p.Ser24Ser), rs144023942, gnomAD 8-117146954-T-C, CADD 4.29
- E26K (p.Glu26Lys), gnomAD 8-117146958-G-A, REVEL 0.09, CADD 21.20
- L27F (p.Leu27Phe), ExAC rs759603427, gnomAD rs759603427, REVEL 0.07, CADD 17.70
- L27P (p.Leu27Pro), ExAC rs765261676, TOPMed rs765261676, gnomAD rs765261676, REVEL 0.31, CADD 21.20
- L27L (p.Leu27Leu), gnomAD 8-117146963-C-G, CADD 1.69
- Q28R (p.Gln28Arg), ExAC rs775751286, TOPMed rs775751286, gnomAD rs775751286, REVEL 0.03, CADD 13.30
- Q28H (p.Gln28His), gnomAD 8-117146966-A-C, REVEL 0.06, CADD 6.43
- Q28Q (p.Gln28Gln), rs763078920, gnomAD 8-117146966-A-G, CADD 2.94
- Q29* (p.Gln29Ter), gnomAD rs1226820997, CADD 35.00
- Q29E (p.Gln29Glu), gnomAD 8-117146967-C-G, REVEL 0.09, CADD 12.60
- K30T (p.Lys30Thr), gnomAD rs1474212116, REVEL 0.07, CADD 17.20
- K30E (p.Lys30Glu), gnomAD 8-117146970-A-G, REVEL 0.25, CADD 21.90
- P31L (p.Pro31Leu), rs777302856, NCI-TCGA Cosmic COSV6996, ExAC rs777302856, REVEL 0.06, CADD 12.20, Variant assessed as somatic; moderate impact.
- P31Q (p.Pro31Gln), NCI-TCGA Cosmic COSV6996, Variant assessed as somatic; moderate impact.
- P31R (p.Pro31Arg), ExAC rs777302856, TOPMed rs777302856, gnomAD rs777302856
- P31T (p.Pro31Thr), NCI-TCGA Cosmic COSV6997, SIFT 0.16, Variant assessed as somatic; moderate impact.
- P31P (p.Pro31Pro), rs751667454, gnomAD 8-117146975-G-A, CADD 3.24
- V32E (p.Val32Glu), NCI-TCGA Cosmic COSV6996, Variant assessed as somatic; moderate impact.
- V32L (p.Val32Leu), ExAC rs757655293, TOPMed rs757655293, gnomAD rs757655293, SIFT 1.00
- V32M (p.Val32Met), ExAC rs757655293, TOPMed rs757655293, gnomAD rs757655293, REVEL 0.04, CADD 6.37
- V32V (p.Val32Val), rs1241812840, gnomAD 8-117146978-G-A, CADD 8.83
- N33H (p.Asn33His), gnomAD 8-117146979-A-C, REVEL 0.09, CADD 20.20
- N33S (p.Asn33Ser), gnomAD 8-117146980-A-G, REVEL 0.07, CADD 15.80
- K34E (p.Lys34Glu), ExAC rs767831564, gnomAD rs767831564, REVEL 0.14, CADD 14.70
- K34S (p.Lys34Ser), rs587777582, gnomAD 8-117146981-TAAAG, CADD 23.90
- D35H (p.Asp35His), gnomAD 8-117146985-G-C, REVEL 0.06, CADD 20.30
- Q36* (p.Gln36Ter), gnomAD rs1821928621, CADD 34.00
- Q36R (p.Gln36Arg), Ensembl rs1821928719, SIFT 0.51
- Q36K (p.Gln36Lys), gnomAD 8-117146988-C-A, REVEL 0.15, CADD 12.30
- Q36P (p.Gln36Pro), gnomAD 8-117146989-A-C, REVEL 0.20, CADD 10.20
- C37R (p.Cys37Arg), rs141876609, ClinGen CA4853448, ClinVar RCV004459153, 1000Genomes rs141876609, REVEL 0.05, CADD 2.60, Uncertain significance, not specified
- C37Y (p.Cys37Tyr), TOPMed rs1287896728, gnomAD rs1287896728, REVEL 0.08, CADD 0.85
- P38S (p.Pro38Ser), TOPMed rs984636211, gnomAD rs984636211, REVEL 0.05, CADD 9.68, Uncertain significance, not specified
- P38P (p.Pro38Pro), gnomAD 8-117146996-C-T, CADD 1.72
- R39G (p.Arg39Gly), TOPMed rs1448460756, gnomAD rs1448460756, REVEL 0.06, CADD 5.80
- R39R (p.Arg39Arg), gnomAD 8-117146999-A-G, CADD 6.82
- E40D (p.Glu40Asp), gnomAD rs1374352556, REVEL 0.06, CADD 12.00
- E40Q (p.Glu40Gln), ExAC rs756658613, gnomAD rs756658613, REVEL 0.05, CADD 16.20
- E40A (p.Glu40Ala), gnomAD 8-117147001-A-C, REVEL 0.05, CADD 19.60
- R41I (p.Arg41Ile), gnomAD rs927398701, REVEL 0.03, CADD 13.60
- R41K (p.Arg41Lys), gnomAD rs927398701
- R41T (p.Arg41Thr), gnomAD rs927398701, REVEL 0.04, CADD 9.91
- R41G (p.Arg41Gly), gnomAD 8-117147003-A-G, REVEL 0.04, CADD 13.40
- R41R (p.Arg41Arg), gnomAD 8-117147003-A-C, CADD 4.97
- P42R (p.Pro42Arg), Ensembl rs2130965851, REVEL 0.16, CADD 14.90
- P42S (p.Pro42Ser), ExAC rs780519971, TOPMed rs780519971, gnomAD rs780519971, REVEL 0.06, CADD 15.70, Uncertain significance, not specified
- P42T (p.Pro42Thr), ExAC rs780519971, TOPMed rs780519971, gnomAD rs780519971, SIFT 0.09, Uncertain significance
- P42L (p.Pro42Leu), gnomAD 8-117147007-C-T, REVEL 0.17, CADD 18.10
- E43D (p.Glu43Asp), Ensembl rs1821929824, REVEL 0.06, CADD 18.00
- E44D (p.Glu44Asp), rs143592691, ClinGen CA4853451, ClinVar RCV004196155, ESP rs143592691, REVEL 0.03, CADD 8.69, Uncertain significance, not specified
- E44G (p.Glu44Gly), TOPMed rs1821930036, gnomAD rs1821930036, REVEL 0.07, CADD 10.50
- E44K (p.Glu44Lys), rs267601738, NCI-TCGA Cosmic COSV6997, Ensembl rs267601738, AlphaMissense 0.07, MetaLR 0.14, Variant assessed as somatic; moderate impact.
- E44V (p.Glu44Val), NCI-TCGA TCGA novel, TOPMed rs1821930036, gnomAD rs1821930036, SIFT 0.26, Variant assessed as somatic; moderate impact.
- L45M (p.Leu45Met), rs148043363, ClinGen CA4853452, ClinVar RCV004182147, 1000Genomes rs148043363, REVEL 0.17, CADD 15.60, Uncertain significance, not specified
- L45L (p.Leu45Leu), rs148043363, gnomAD 8-117147015-C-T, CADD 6.10
- L45P (p.Leu45Pro), gnomAD 8-117147016-T-C, REVEL 0.07, CADD 10.40
- E46K (p.Glu46Lys), TOPMed rs1821930500, REVEL 0.04, CADD 16.90
- S47* (p.Ser47Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G48E (p.Gly48Glu), NCI-TCGA Cosmic COSV6997, Variant assessed as somatic; moderate impact.
- G48R (p.Gly48Arg), ExAC rs777483638, gnomAD rs777483638, SIFT 0.13
- G49S (p.Gly49Ser), TOPMed rs1364161992, gnomAD rs1364161992, REVEL 0.11, CADD 10.00, Uncertain significance, not specified
- G49V (p.Gly49Val), gnomAD 8-117147028-G-T, REVEL 0.03, CADD 5.64
- G49G (p.Gly49Gly), rs1381917578, gnomAD 8-117147029-C-T, CADD 14.80
- M50I (p.Met50Ile), ExAC rs746582624, TOPMed rs746582624, gnomAD rs746582624, MetaLR 0.06, MetaSVM -1.10
- Y51N (p.Tyr51Asn), gnomAD rs1309409022, REVEL 0.08, MetaLR 0.13
- H52N (p.His52Asn), NCI-TCGA Cosmic COSV1014, cosmic curated COSV10143, MetaLR 0.38, MetaSVM -0.28, Variant assessed as somatic; moderate impact.
- C53Y (p.Cys53Tyr), TOPMed rs917503960, gnomAD rs917503960, REVEL 0.42, MetaLR 0.36
- C53C (p.Cys53Cys), rs1563625824, gnomAD 8-117147041-C-T, CADD 8.89
- H54L (p.His54Leu), ESP rs141730422, ExAC rs141730422, TOPMed rs141730422, gnomAD rs141730422, REVEL 0.52, MetaLR 0.36
- H54P (p.His54Pro), ESP rs141730422, ExAC rs141730422, TOPMed rs141730422, gnomAD rs141730422, REVEL 0.53, MetaLR 0.36
- H54R (p.His54Arg), ESP rs141730422, ExAC rs141730422, TOPMed rs141730422, gnomAD rs141730422, MetaLR 0.36, MetaSVM -0.28
- H54Y (p.His54Tyr), gnomAD 8-117147042-C-T, REVEL 0.40, MetaLR 0.33
- H54H (p.His54His), rs377269953, gnomAD 8-117147044-C-T, CADD 4.06
- S55R (p.Ser55Arg), Ensembl rs1586585878, NCI-TCGA Cosmic COSV6997, cosmic curated COSV69970, MetaLR 0.09, MetaSVM -1.07, Variant assessed as somatic; moderate impact.
- S55G (p.Ser55Gly), gnomAD 8-117147045-A-G, REVEL 0.06, MetaLR 0.09
- G56G (p.Gly56Gly), gnomAD 8-117147050-C-T, CADD 4.54
- S57F (p.Ser57Phe), cosmic curated COSV69968, TOPMed rs1328527565, gnomAD rs1328527565, REVEL 0.07, MetaLR 0.11
- S57Y (p.Ser57Tyr), NCI-TCGA Cosmic COSV6996, NCI-TCGA Cosmic COSV6997, cosmic curated COSV69971, REVEL 0.10, MetaLR 0.13, Variant assessed as somatic; moderate impact.
- S57S (p.Ser57Ser), rs745627696, gnomAD 8-117147053-C-T, CADD 6.77
- K58Q (p.Lys58Gln), rs1246625721, ClinGen CA371911875, ClinVar RCV004142327, TOPMed rs1246625721, REVEL 0.06, MetaLR 0.11, Likely benign, not specified
- K58R (p.Lys58Arg), TOPMed rs1821932547, MetaLR 0.11, MetaSVM -1.06
- P59A (p.Pro59Ala), ExAC rs769900402, gnomAD rs769900402, REVEL 0.09, MetaLR 0.07
- P59S (p.Pro59Ser), ExAC rs769900402, gnomAD rs769900402, REVEL 0.07, MetaLR 0.10
- P59P (p.Pro59Pro), rs1821933015, gnomAD 8-117147059-C-T, CADD 1.79
- T60K (p.Thr60Lys), ExAC rs775528421, gnomAD rs775528421, REVEL 0.08, MetaLR 0.12
- T60Q (p.Thr60Gln), rs1041883539, gnomAD 8-117147056-GC-G, CADD 20.00
- T60T (p.Thr60Thr), gnomAD 8-117147062-A-G, CADD 0.17
- E61* (p.Glu61Ter), NCI-TCGA Cosmic COSV6997, Variant assessed as somatic; high impact.
- E61G (p.Glu61Gly), gnomAD rs1430961885, REVEL 0.11, MetaLR 0.10
- E61K (p.Glu61Lys), rs1376637053, NCI-TCGA Cosmic COSV6997, cosmic curated COSV69976, TOPMed rs1376637053, REVEL 0.18, MetaLR 0.15, Variant assessed as somatic; moderate impact.
- E61Q (p.Glu61Gln), rs926149634, gnomAD 8-117147058-C-CCA, CADD 22.00
- K62M (p.Lys62Met), NCI-TCGA Cosmic COSV6997, cosmic curated COSV69970, MetaLR 0.10, MetaSVM -1.01, Variant assessed as somatic; moderate impact.
- K62E (p.Lys62Glu), gnomAD 8-117147066-A-G, REVEL 0.08, MetaLR 0.08
- K62R (p.Lys62Arg), gnomAD 8-117147067-A-G, REVEL 0.07, MetaLR 0.09
- G63E (p.Gly63Glu), 1000Genomes rs150548337, ESP rs150548337, ExAC rs150548337, TOPMed rs150548337, REVEL 0.15, MetaLR 0.10, Uncertain significance, not specified
- G63R (p.Gly63Arg), NCI-TCGA Cosmic COSV6996, cosmic curated COSV69969, Variant assessed as somatic; moderate impact.
- G63V (p.Gly63Val), NCI-TCGA TCGA novel, MetaLR 0.10, MetaSVM -1.05, Variant assessed as somatic; moderate impact.
- A64E (p.Ala64Glu), ExAC rs774478941, TOPMed rs774478941, gnomAD rs774478941, REVEL 0.06, MetaLR 0.08
- A64V (p.Ala64Val), rs774478941, NCI-TCGA Cosmic COSV6996, cosmic curated COSV69968, ExAC rs774478941, REVEL 0.04, MetaLR 0.09, Variant assessed as somatic; moderate impact.
- A64R (p.Ala64Arg), gnomAD 8-117147067-AG-A, CADD 14.30
- A64A (p.Ala64Ala), rs762011807, gnomAD 8-117147074-G-A, CADD 0.08
- N65S (p.Asn65Ser), TOPMed rs1408335894, MetaLR 0.09, MetaSVM -1.03
- E66K (p.Glu66Lys), cosmic curated COSV10143, 1000Genomes rs200895741, ExAC rs200895741, gnomAD rs200895741, REVEL 0.10, MetaLR 0.11
- Y67Y (p.Tyr67Tyr), rs750839622, gnomAD 8-117147083-C-T, CADD 0.07
- p.Tyr67 Ala68insLeu, gnomAD 8-117147083-C-CTT, CADD 2.91
- A68T (p.Ala68Thr), ESP rs200572112, ExAC rs200572112, TOPMed rs200572112, gnomAD rs200572112, REVEL 0.01, MetaLR 0.10, Uncertain significance, not specified
- A68V (p.Ala68Val), TOPMed rs1821934944, MetaLR 0.08, MetaSVM -1.07
- A68G (p.Ala68Gly), gnomAD 8-117147085-C-G, REVEL 0.04, MetaLR 0.09
- A68A (p.Ala68Ala), rs1364279692, gnomAD 8-117147086-C-T, CADD 4.17
- Y69C (p.Tyr69Cys), 1000Genomes rs547844916, ExAC rs547844916, TOPMed rs547844916, gnomAD rs547844916, MetaLR 0.10, MetaSVM -1.03
- Y69S (p.Tyr69Ser), 1000Genomes rs547844916, ExAC rs547844916, TOPMed rs547844916, gnomAD rs547844916, REVEL 0.08, MetaLR 0.11
- A70T (p.Ala70Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A70V (p.Ala70Val), NCI-TCGA Cosmic COSV6996, cosmic curated COSV69969, MetaLR 0.32, MetaSVM -0.43, Variant assessed as somatic; moderate impact.
- K71Q (p.Lys71Gln), gnomAD rs1821935420, REVEL 0.06, MetaLR 0.16
- K71R (p.Lys71Arg), NCI-TCGA Cosmic COSV6996, cosmic curated COSV69969, MetaLR 0.16, MetaSVM -0.90, Variant assessed as somatic; moderate impact.
Public SLC30A8 analysis runs
- SLC30A8 analysis run — SLC30A8 (716 variants) — completed 2026-08-19